Breast Cancer Risk Assessment & Precision Screening
personalized ccreening based on your individual risk
Breast cancer risk varies from person to person. At CMoC, breast cancer risk assessment goes beyond age-based guidelines to provide a more personalized approach to breast health.
By integrating clinical history, breast density, and genetic risk information when appropriate, clinicians can better estimate short-term and lifetime breast cancer risk and tailor screening recommendations accordingly.
What Is Breast Cancer Risk Assessment?
Breast cancer risk assessment evaluates factors such as family history, personal medical history, reproductive history, breast density, and inherited risk to help determine an individual’s likelihood of developing breast cancer over time.
This information is used to guide screening strategy, not to diagnose cancer.
Precision Screening Strategies
Based on an individual’s risk profile, clinicians may recommend a personalized screening approach that can include:
Routine mammography
Supplemental imaging for dense breast tissue
Breast MRI for higher-risk patients
This ensures screening is proactive, appropriate, and aligned with individual risk rather than relying solely on population averages.
Breast Cancer Risk Assessment Testing Options
Breast cancer risk assessment uses a combination of clinical data, validated risk models, and genetic information to better estimate an individual’s short-term and lifetime risk of developing breast cancer. Rather than relying solely on age, this approach helps identify who may benefit from earlier screening, additional imaging, or closer surveillance.
At CMoC, testing options may incorporate personal and family history, breast density, and inherited risk factors to guide a more precise screening strategy. These assessments are used to inform screening decisions and preventive planning, not to diagnose cancer.
The testing options listed below represent different tools used to support personalized breast cancer risk assessment and precision screening. Your clinician will help determine which options are appropriate based on your individual risk profile and health goals.
Risk Assessment
The Tyrer-Cuzick (TC) v8 model is a calculator that estimates your personal risk of developing breast cancer by looking at factors like age, family history, breast density, and reproductive history. It gives both a 10-year and lifetime risk percentage, helping your provider decide whether you may benefit from earlier or more frequent screening, additional imaging like MRI, or preventive strategies. It’s not a diagnostic test, but it helps guide a more personalized approach to your breast health.
Polygenic Risk Score
Estimates a person’s inherited risk for common diseases by combining the effects of many small genetic variations into a single, population-based risk measure used to guide prevention and early screening.
Genetic Testing
Genetic testing analyzes a person’s DNA to identify inherited variants that may influence disease risk, support diagnosis, guide treatment decisions, and inform personalized prevention and long-term health planning.
Personalized Imaging
A breast MRI provides highly detailed images of breast tissue and can detect abnormalities that may not appear on a mammogram or ultrasound. It is especially helpful for women with dense breasts or those at higher risk for breast cancer. MRI can find cancers earlier, clarify unclear findings from other imaging, and provide additional information before surgery. It uses no radiation and is one of the most sensitive tools available for detecting breast cancer.
Personalize Your Breast Cancer Screening Plan
Understanding risk is the first step toward more informed screening decisions. Our clinicians will help you interpret your risk assessment and determine which screening approach is most appropriate for you.